ARC Discovery - $521,800

PROJECT SUMMARY: The aim of this project is to develop a particle engineering technology, based on microfluidics, that results in micro- droplets with controlled geometry and morphology. These Smartdrops will be used to target respiratory macrophages for the delivery of inflammatory suppressants, since their dimensions can be controlled to optimise lung deposition and macrophage recognition. The project aims to develop an aerosol inhaler and a series of physico-chemical and in vitro characterisation tools that will be used to study Smartdrop formation, aerosol properties and their interactions with cells. The outcome of this project is intended to be the development of a technology for treating chronic lung inflammation which could also be utilised for a number of other commercial applications.